Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.190
-0.180 (-5.34%)
At close: Jun 27, 2025, 4:00 PM
3.160
-0.030 (-0.94%)
After-hours: Jun 27, 2025, 7:14 PM EDT
IMDX Market Cap
IMDX has a market cap or net worth of $91.23 million as of June 27, 2025. Its market cap has increased by 149.27% in one year.
Market Cap
91.23M
Enterprise Value
65.54M
1-Year Change
149.27%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $91.23M, a decrease of -60.11%. That is a compound annual growth rate of -9.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 91.50M | 128.18% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.77B |
| Johnson & Johnson | 366.52B |
| AbbVie | 326.87B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 277.94B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.72B |
| AstraZeneca | 215.99B |